From: Association between PEG3 DNA methylation and high-grade cervical intraepithelial neoplasia
 | All, N = 419 ORa (95% CI) | Black, N = 168 ORa (95% CI) | White, N = 206 ORa (95% CI) | |||
---|---|---|---|---|---|---|
Regulatory DMR | CIN2+ vs. ≤CIN1 | CIN3+ vs. ≤CIN2 | CIN2+ vs. ≤CIN1 | CIN3+ vs. ≤CIN2 | CIN2+ vs. ≤ CIN1 | CIN3+ vs. ≤ CIN2 |
PEG3 | 1.16 (0.87–1.56) | 0.79 (0.48–1.31) | 1.31 (0.76–2.25) | 1.71 (0.71–4.10) | 1.13 (0.73–1.75) | 0.70 (0.37–1.32) |
PLAGL1/HYMAI | 1.01 (0.73–1.38) | 0.92 (0.51–1.66) | 0.82 (0.44–1.52) | 1.15 (0.51–2.58) | 0.98 (0.63–1.52) | 0.75 (0.35–1.61) |
Kv DMR | 1.21 (0.80–1.83) | 0.91 (0.43–1.89) | 1.22 (0.68–2.17) | 1.47 (0.67–3.21) | 1.58 (0.74–3.35) | 0.88 (0.32–2.26) |
IGF2/H19 | 1.15 (0.72–1.82) | 0.76 (0.41–1.42) | 0.43 (0.17–1.06) | 0.43 (0.14–1.31) | 1.61 (0.85–3.06) | 0.93 (0.44–2.00) |
IGF2AS | 1.13 (0.93–1.38) | 1.16 (0.82–1.65) | 1.20 (0.85–1.71) | 1.22 (0.73–2.03) | 1.12 (0.85–1.48) | 1.08 (0.72–1.61) |
MESTIT1/MEST | 1.08 (0.74–1.58) | 0.90 (0.48–1.70) | 1.14 (0.59–2.20) | 0.36 (0.13–1.98) | 0.88 (0.52–1.47) | 1.11 (0.51–2.42) |
PEG10 | 1.15 (0.73–1.81) | 1.04 (0.48–2.23) | 1.25 (0.50–3.13) | 1.73 (0.45–6.74) | 1.00 (0.54–1.85) | 0.82 (0.32–2.08) |
MEG3 | 1.01 (0.79–1.28) | 1.38 (0.95–1.99) | 0.95 (0.63–1.44) | 1.06 (0.60–1.88) | 1.13 (0.80–1.62) | 1.58 (0.97–2.58) |